• Freedom
  • Innovation
  • Growth

Health Care

February 26, 2024

Counterfeit Drugs: Losing Weight Rather than Losing Your Life (Audio: Podcast)

Counterfeit drugs has always been a serious problem, and a problem we’ve worked on here at IPI for many years. And it’s a topic that is back for a return engagement as demand for “miracle” weight loss drugs is creating opportunity for counterfeiters. IPI’s Resident Scholar Dr. Merrill Matthews guides us on the problems with counterfeit drugs and why you should be cautious about deals on drugs that seem too good to be true.

January 19, 2024

Don't Impose New Fears on Old Vaccines (Audio: Podcast)

IPI’s Resident Scholar Dr. Merrill Matthews explains how increasing vaccine skepticism threatens outbreaks of dreaded diseases that have been under control for decades. With IPI President Tom Giovanetti.

December 11, 2023

Trump Is Right--Obamacare Sucks (Audio: Podcast)

Recently Donald Trump posted on his Truth Social media platform that “Obamacare sucks.” We at IPI don’t always agree with Trump’s sentiments, but in this case, IPI Resident Scholar Dr. Merrill Matthews explains why Trump is right, and Obamacare has only made healthcare worse. With IPI President Tom Giovanetti.

December 7, 2023

When the Biden Administration Goes Marching In (Audio: Podcast)

Today the Biden administration announced a proposal to aggressively use federal “march in” rights to seize patents from pharmaceutical companies and “other inventions.” IPI Resident Scholar Dr. Merrill Matthews explains what march in rights are, and why what the Biden administration is proposing is very, very bad. With IPI President Tom Giovanetti.

September 5, 2023

Conservative Health Care Reforms Ready to Go (Audio: Podcast)

Galen Institute President Grace-Marie Turner joins IPI's Merrill Matthews to discuss various conservative health care reform proposals that, if passed, would provide people with more insurance-coverage options and patients with more freedom to choose the care that's best for them.

August 7, 2023

A New (?) Conservative Blueprint for Healthcare Reform (Audio: Podcast)

IPI Resident Scholar and healthcare policy expert Dr. Merrill Matthews explains a new-ish effort on the part of some conservative policy experts, which sound to IPI President Tom Giovanetti an awfully lot like the same sound healthcare policies conservatives have been pushing for the last two decades.


July 17, 2023

If Obamacare Is so Great, Why Limit Other Options? (Audio: Podcast)

IPI Resident Scholar Dr. Merrill Matthews explains “bridge” or “gap” short term health insurance policies, which have functioned as less costly alternatives to Obamacare for many people. But progressives don’t actually like Americans to have choice, IPI President Tom Giovanetti reminds us, and that’s why the Biden administration announced steps last week to severely limit access to what they characterize as “junk” insurance policies. But if Obamacare is so great, why be worried about people choosing alternatives? Because, for one thing, Obamacare ain’t all that great. And for another thing, progressives don’t really believe in consumer choice. Free market economic proposals, by contrast, start with an assumption of consumer choice.

June 10, 2023

The Feds Make Drug Companies an Offer they Can't Refuse (Audio: Podcast)

The dishonestly named “Inflation Reduction Act” creates an explicit price controls mechanism for prescription drugs under Medicare. This unravels the market protection mechanism in the Medicare Prescription Drug Benefit known as the nonintervention clause. IPI Resident Scholar Dr. Merrill Matthews explains how these price controls will be harmful to prescription drug innovation, and the constitutional grounds on which a legal challenge by Merck might be successful. With IPI President Tom Giovanetti.

May 26, 2023

Reconsidering Drug Pricing (Audio: Podcast)

by Merrill Matthews, Dr. Robert Popovian

Prescription drug issues are back on the Washington's front-burner. IPI Resident Scholar Merrill Matthews talks with Dr. Robert Popovian about his new paper, which highlights how recent developments—including insulin pricing, PBMs, the Inflation Reduction Act and Medicaid—are moving the drug companies to reconsider how they price their products. 

April 24, 2023

IPI Policy Basics: What Is Intellectual Property, Why Is it Important, and Why Is it Controversial? (Audio: Podcast)

In recognition of World IP Day, the Institute for Policy Innovation, an accredited Non-Governmental Organization affiliated with the World Intellectual Property Organization (WIPO), discusses the importance of intellectual property protection. With IPI Senior Research Fellow Bartlett Cleland and IPI Resident Scholar Dr. Merrill Matthews.

Total Records: 272